Metformin Chemical Structure
1.Identification SummaryFirst-line oral antihyperglycemic (biguanide) used in type 2 diabetes mellitus; lowers hepatic glucose output, improves insulin sensitivity, … Read more
Type 2 Diabetes
Mechanism of Action of Empagliflozin
Introduction Empagliflozin is an oral sodium–glucose co-transporter 2 (SGLT2) inhibitor that lowers blood glucose by promoting urinary glucose … Read more
Mechanism of Action of Dapagliflozin
Introduction Dapagliflozin is an oral sodium–glucose co-transporter 2 (SGLT2) inhibitor, used to treat type 2 diabetes mellitus (T2DM). … Read more
Mechanism of Action of Sitagliptin
Introduction Sitagliptin is an oral dipeptidyl peptidase‑4 (DPP‑4) inhibitor used to manage type 2 diabetes mellitus (T2DM). It … Read more
Mechanism of Action of Liraglutide
Introduction Liraglutide is a long-acting GLP‑1 receptor agonist, injected once daily. It’s used for type 2 diabetes mellitus … Read more
Mechanism of Action of SGLT2Inhibitors
Introduction SGLT2 inhibitors, also known as “gliflozins,” are a class of oral antidiabetic agents primarily used to manage … Read more
Mechanism of Action of Jardiance (Empagliflozin)
Introduction Jardiance (empagliflozin) is a sodium–glucose co-transporter 2 (SGLT2) inhibitor used for type 2 diabetes mellitus (T2DM), heart failure … Read more
Mechanism of Action of Mounjaro (Tirzepatide)
Introduction Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for obesity, is a dual GIP/GLP‑1 receptor … Read more